Markets
← Back to Stocks
ZBH
ZIMMER BIOMET HOLDINGS INC
Health Care · Health Care Equipment
$89.85
+0.86%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Zimmer Biomet shows strength from Q4 sales growth but shares remain pressured 17.9% below 52-week highs.
ZBH reported 10.9% net sales increase in Q4 2025 with consensus analyst price target of $102.43. Shares declined 17.9% from 52-week high despite operational gains. Stifel Nicolaus maintains Buy rating from March 6. Company faces medical device sector headwinds but retains analyst support.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$17.8B
P/E (TTM)25.3
Forward P/E10.0
Beta0.59
Div Yield108.00%
Prev Close$89.08
RSI (14-Day)
27Oversold
0305070100
52-Week Range
$84.59$89.85$114.44
From High-21.5%
From Low+6.2%
Moving Averages
50d SMA
$92.28-2.6%
200d SMA
$94.95-5.4%
Price below 200d MA — bearish structure.
Returns
1W
-3.0%
1M
-8.6%
3M
-0.9%
6M
-9.6%
1Y
-19.6%
YTD
-0.2%
Volume
Today53K
20d Avg2.0M
Ratio0.03x